These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14612600)

  • 1. Prostate cancer management: (1) an update on localised disease.
    Bott SR; Birtle AJ; Taylor CJ; Kirby RS
    Postgrad Med J; 2003 Oct; 79(936):575-80. PubMed ID: 14612600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical radiotherapy for prostate cancer.
    Parker CC; Dearnaley DP
    Cancer Treat Rev; 2003 Jun; 29(3):161-9. PubMed ID: 12787711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of the Different Treatments and Management for Prostate Cancer and Fertility.
    Tran S; Boissier R; Perrin J; Karsenty G; Lechevallier E
    Urology; 2015 Nov; 86(5):936-41. PubMed ID: 26368508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature.
    Nguyen PL; D'Amico AV; Lee AK; Suh WW
    Cancer; 2007 Oct; 110(7):1417-28. PubMed ID: 17694553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation.
    Baumann BC; Baumann JC; Christodouleas JP; Soffen E
    Brachytherapy; 2017; 16(2):291-298. PubMed ID: 28139422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
    Gomez-Veiga F; Mariño A; Alvarez L; Rodriguez I; Fernandez C; Pertega S; Candal A
    BJU Int; 2012 Feb; 109 Suppl 1():17-21. PubMed ID: 22239225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of prostate cancer care: from curative intent to palliation.
    Ali AS; Hamdy FC
    Curr Urol Rep; 2007 May; 8(3):245-52. PubMed ID: 17459275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
    Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
    Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent prostate brachytherapy in men with clinically localised prostate cancer.
    Potters L
    Clin Oncol (R Coll Radiol); 2003 Sep; 15(6):301-15. PubMed ID: 14524482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Biochemical Recurrence after Primary Curative Treatment for Prostate Cancer: A Review.
    Artibani W; Porcaro AB; De Marco V; Cerruto MA; Siracusano S
    Urol Int; 2018; 100(3):251-262. PubMed ID: 29161715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
    Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
    BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technological advances in radiotherapy for the treatment of localised prostate cancer.
    Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
    Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic options and controversies in the management of prostate cancer].
    Peyromaure M; Thiounn N
    Rev Prat; 2003 Dec; 53(20):2263-7. PubMed ID: 15018081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for localized prostate cancer: An Asian Prostate HDR-BT Consortium.
    Ishiyama H; Kamitani N; Kawamura H; Kato S; Aoki M; Kariya S; Matsumura T; Kaidu M; Yoshida K; Hashimoto Y; Noda Y; Lim KHC; Kawase T; Takahashi T; Inaba K; Kumano M; Yoshikawa N; Yoshioka Y; Nakamura K; Hiratsuka J; Itami J; Hayakawa K
    Brachytherapy; 2017; 16(3):503-510. PubMed ID: 28222973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.
    Allen GW; Howard AR; Jarrard DF; Ritter MA
    Cancer; 2007 Oct; 110(7):1405-16. PubMed ID: 17685384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
    Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
    Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.